Litcius/Paper detail

Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster

Chaitanya Kurhade, Jing Zou, Hongjie Xia, Mingru Liu, Hope C. Chang, Ping Ren, Xuping Xie, Pei‐Yong Shi

2022Nature Medicine447 citationsDOIOpen Access PDF

Topics & Concepts

Bivalent (engine)NeutralizationBooster (rocketry)TiterBooster doseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMessenger RNACoronavirus disease 2019 (COVID-19)MedicineChemistryBiologyGeneGeneticsVirusPhysicsInternal medicineInfectious disease (medical specialty)DiseaseOrganic chemistryAstronomyMetalSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral gastroenteritis research and epidemiology
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster | Litcius